rs145891889

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001042492.3(NF1):​c.1994C>T​(p.Ser665Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000355 in 1,613,520 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S665S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 2 hom. )

Consequence

NF1
NM_001042492.3 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:22O:1

Conservation

PhyloP100: 2.37

Publications

15 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0058389306).
BP6
Variant 17-31225243-C-T is Benign according to our data. Variant chr17-31225243-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 134881.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00196 (299/152216) while in subpopulation AFR AF = 0.00681 (283/41544). AF 95% confidence interval is 0.00616. There are 0 homozygotes in GnomAd4. There are 133 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 299 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042492.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
NM_001042492.3
MANE Select
c.1994C>Tp.Ser665Phe
missense
Exon 17 of 58NP_001035957.1P21359-1
NF1
NM_000267.4
c.1994C>Tp.Ser665Phe
missense
Exon 17 of 57NP_000258.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
ENST00000358273.9
TSL:1 MANE Select
c.1994C>Tp.Ser665Phe
missense
Exon 17 of 58ENSP00000351015.4P21359-1
NF1
ENST00000356175.7
TSL:1
c.1994C>Tp.Ser665Phe
missense
Exon 17 of 57ENSP00000348498.3P21359-2
NF1
ENST00000579081.6
TSL:1
n.1994C>T
non_coding_transcript_exon
Exon 17 of 58ENSP00000462408.2J3KSB5

Frequencies

GnomAD3 genomes
AF:
0.00198
AC:
301
AN:
152098
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00688
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000602
AC:
151
AN:
250986
AF XY:
0.000310
show subpopulations
Gnomad AFR exome
AF:
0.00831
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000188
AC:
274
AN:
1461304
Hom.:
2
Cov.:
31
AF XY:
0.000146
AC XY:
106
AN XY:
726972
show subpopulations
African (AFR)
AF:
0.00646
AC:
216
AN:
33442
American (AMR)
AF:
0.000380
AC:
17
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111604
Other (OTH)
AF:
0.000431
AC:
26
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00196
AC:
299
AN:
152216
Hom.:
0
Cov.:
32
AF XY:
0.00179
AC XY:
133
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00681
AC:
283
AN:
41544
American (AMR)
AF:
0.000393
AC:
6
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68012
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000744
Hom.:
0
Bravo
AF:
0.00217
ESP6500AA
AF:
0.00658
AC:
29
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000733
AC:
89
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
7
Neurofibromatosis, type 1 (8)
-
-
4
not specified (5)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
not provided (3)
-
-
2
Neurofibromatosis, familial spinal (2)
-
-
1
Café-au-lait macules with pulmonary stenosis (1)
-
-
1
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype (1)
-
-
1
Neurofibromatosis-Noonan syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.45
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.028
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.87
D
M_CAP
Uncertain
0.086
D
MetaRNN
Benign
0.0058
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
L
PhyloP100
2.4
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.93
N
REVEL
Benign
0.24
Sift
Benign
0.032
D
Sift4G
Benign
0.22
T
Polyphen
0.0
B
Vest4
0.82
MVP
0.80
MPC
0.77
ClinPred
0.038
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.072
gMVP
0.34
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145891889; hg19: chr17-29552261; COSMIC: COSV62199685; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.